10/27/2020  9:10:00 PM Chg. -1.12 Volume Bid10/27/2020 Ask10/27/2020 Market Capitalization Dividend Y. P/E Ratio
33.21USD -3.26% 261,921
Turnover: 7.02 mill.
31.85Bid Size: 100 41.00Ask Size: 100 1.66 bill.USD 0.00% 11.82

Business description

Prestige Consumer Healthcare, Inc. markets and distributes brand name over-the-counter healthcare products throughout the U.S. and Canada, Australia, and in certain other international markets. The Company’s brands include Monistat® and Summer’s Eve® women's health products, BC® and Goody's® pain relievers, Clear Eyes® eye care products, DenTek® and The Doctor's® oral care products, Dramamine® motion sickness treatments, Fleet® enemas and glycerin suppositories, Chloraseptic® sore throat treatments, Compound W® wart treatments, Little Remedies® pediatric over-the-counter products, Efferdent® denture care products, Luden's® throat drops, Debrox® earwax remover, Gaviscon® antacid in Canada, and Hydralyte® rehydration products and the Fess® line of nasal and sinus care products in Australia.
 

Management board & Supervisory board

CEO
Ron Lombardi
Management board
Christine Sacco, Adel Mekhail, Jeff Thompson, Jeff Zerillo, Mary Beth Fritz, William P'Pool
Supervisory board
Dr. Gary E. Costley, Christopher J. Coughlin, Dawn M. Zier, James M. Jenness, John E. Byom, Natale S. Ricciardi, Ron Lombardi, Sheila A. Hopkins
 

Company data

Name: Prestige Consumer Healthcare, Inc.
Address: 660 White Plains Road,Tarrytown, New York 10591, USA
Phone: +1-914-524-6800
Fax: -
E-mail: Irinquiries@prestigebrands.com
Internet: www.prestigebrandsinc.com/
Industry: Consumer Goods
Sector: Cosmetics
Sub sector: Cosmetics
End of financial year: 3/31
Free Float: 68.86%
IPO date: -

Investor relations

Name: Phil Terpolilli
IR phone: +1-914-524-6819
IR Fax: -
IR e-mail: -

Company calendar

CW 45 | 11/5/2020 Interim Report 2nd Quarter/6 Months
 

Main Shareholders

Freefloat
 
68.86%
BlackRock, Inc.
 
13.30%
The Vanguard Group
 
10.14%
Dimensional Fund Advisors LP
 
7.70%